SCHEMBL752888

SCHEMBL752888

O=S(=O)(Cc1ccc(F)cc1)C(I)I

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
EGFR P00533 2/20 0.40
ERBB2 P04626 2/20 0.40
LMNA P02545 2/20 0.39
USP2 O75604 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HTT P42858 1/20 0.39
IDO1 P14902 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1271876 0.81 EGFR (0.44) KMT2AEGFRERBB2LMNAUSP2
SCHEMBL746514 0.79 MEN1 (0.44) KMT2AEGFRERBB2IDO1L3MBTL1
SCHEMBL751781 0.79 EGFR (0.40) KMT2AEGFRERBB2POLBTAAR1
SCHEMBL20682260 0.79 HTT (0.46) KMT2AEGFRERBB2LMNANPSR1
SCHEMBL753837 0.79 KMT2A (0.49) KMT2ALMNAIDO1GAATDP1
SCHEMBL751656 0.79 LOXL2 (0.43) KMT2AEGFRERBB2LMNAUSP2
SCHEMBL750558 0.78 CA2 (0.52) KMT2ALOXL2HPGDCYP2C19
SCHEMBL422010 0.75 USP2 (0.51) KMT2AEGFRERBB2LMNAUSP2
SCHEMBL752330 0.75 LDHA (0.49) KMT2AHTTIDO1POLB
SCHEMBL9421733 0.73 FAAH (0.62) KMT2AEGFRERBB2LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M KMT2A 2043/4885EGFR 2547/4885ERBB2 2343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.